Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Psychiatry Reports
Erschienen in: Current Psychiatry Reports 3/2010

01.06.2010

Borderline Personality Disorder and Psychosis: A Review

verfasst von: Sven Barnow, Elisabeth A. Arens, Simkje Sieswerda, Ramona Dinu-Biringer, Carsten Spitzer, Simone Lang

Erschienen in: Current Psychiatry Reports | Ausgabe 3/2010

Einloggen, um Zugang zu erhalten

Abstract

Early views of borderline personality disorder (BPD) were based on the idea that patients with this pathology were “on the border” of psychosis. However, more recent studies have not supported this view, although they have found evidence of a malevolent interpersonal evaluation and a significant proportion of BPD patients showing psychotic symptoms. For example, in one study, 24% of BPD patients reported severe psychotic symptoms and about 75% had dissociative experiences and paranoid ideation. Thus, we start with an overview regarding the prevalence of psychotic symptoms in BPD patients. Furthermore, we report findings of studies investigating the role of comorbidity (eg, post-traumatic stress disorder) in the severity and frequency of psychotic symptoms in BPD patients. We then present results of genetic and neurobiological studies comparing BPD patients with patients with schizophrenia or nonschizophrenic psychotic disorders. In conclusion, this review reveals that psychotic symptoms in BPD patients may not predict the development of a psychotic disorder but are often permanent and severe and need careful consideration by clinicians. Therefore, adequate diagnosis and treatment of psychotic symptoms in BPD patients is emphasized.
Literatur
1.
Stern AJ: Psychoanalytic investigation of and therapy in the borderline group of neuroses. Psychoanal Q 1938, 7:467–489.
2.
Kernberg O: A psychoanalytic theory of personality disorders. In Major Theories of Personality Disorder. Edited by Clarkin JF, Lenzenweger MF. New York: Guilford Press; 1996:106–140.
3.
Edell WS: Role of structure in disordered thinking in borderline and schizophrenic disorders. J Pers Assess 1987, 51:23–41.CrossRefPubMed
4.
O’Leary KM: Borderline personality disorder: neuropsychological testing results. Psychiatr Clin North Am 2000, 23:41–60.CrossRefPubMed
5.
Ruocco AC: The neuropsychology of borderline personality disorder: a meta-analysis and review. Psychiatry Res 2005, 137:191–202.CrossRefPubMed
6.
• Grootens KP, van Luijtelaar G, Buitelaar JK, et al.: Inhibition errors in borderline personality disorder with psychotic-like symptoms. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:267–273. To the best of the knowledge of the authors, this is the only study investigating neuropsychological deficits in both BPD and psychotic patients. This study demonstrated that only patients with BPD and psychotic symptoms have similar cognitive inhibition deficits, as measured with an antisaccade eye task, as patients with schizophrenia.
7.
Leichsenring F, Roth T, Meyer HA: [Cognitive style in borderline patients compared with neurotic patients: Avoidance of ambiguity and reduced abstractness.] Diagnostica 1992, 38:52–65.
8.
Leichsenring F: Discriminating schizophrenics from borderline patients: study with the Holtzman inkblot technique. Psychopathology 1991, 24:225–231.CrossRefPubMed
9.
Westen D, Ludolph P, Lerner H, et al.: Object relations in borderline adolescents. J Am Acad Child Adolesc Psychiatry 1990, 29:338–348.CrossRefPubMed
10.
Veen G, Arntz A: Multidimensional dichotomous thinking characterizes borderline personality disorder. Cogn Ther Res 2000, 24:23–45.CrossRef
11.
Fertuck EA, Jekal A, Song I, et al.: Enhanced ‘reading the mind in the eyes’ in borderline personality disorder compared to healthy controls. Psychol Med 2009, 39:1979–1988.CrossRefPubMed
12.
• Barnow S, Stopsack M, Grabe HJ, et al.: Interpersonal evaluation bias in borderline personality disorder. Behav Res Ther 2009, 47:359–365. This study examined the interpersonal evaluations of individuals with BPD, depressed, and healthy control participants with the thin-slice judgments paradigm. Individuals with BPD judged unknown others as being more negative and aggressive and less positive than the healthy participants, and more aggressive than the depressed individuals. The findings indicate an aggressivistic evaluation bias and elevated levels of interpersonal problems in individuals with BPD.
13.
•• Glaser JP, Van Os J, Thewissen V, Myin-Germeys I: Psychotic reactivity in borderline personality disorder. Acta Psychiatr Scand 2010, 121:125–134. This study examined stress-relatedness and paranoia specificity of psychosis in patients with BPD. BPD patients had more increases in psychotic experiences in relation to daily life stress and also showed the strongest reactivity compared with healthy controls and patients with cluster C personality disorders.
14.
Zanarini MC, Gunderson JG, Frankenburg FR: Cognitive features of borderline personality disorder. Am J Psychiatry 1990, 147:57–63.PubMed
15.
Pope HG Jr, Jonas JM, Hudson JI, et al.: An empirical study of psychosis in borderline personality disorder. Am J Psychiatry 1985, 142:1285–1290.PubMed
16.
Coid J, Yang M, Bebbington P, et al.: Borderline personality disorder: health service use and social functioning among a national household population. Psychol Med 2009, 39:1721–1731.CrossRefPubMed
17.
Yee L, Korner AJ, McSwiggan S, et al.: Persistent hallucinosis in borderline personality disorder. Compr Psychiatry 2005, 46:147–154. (Published erratum appears in Compr Psychiatry 2005, 46:238.)
18.
Meyer TD, Hautzinger M: Prediction of personality disorder traits by psychosis proneness scales in a German sample of young adults. J Clin Psychol 2002, 58:1091–1101.CrossRefPubMed
19.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, edn 4. Washington, DC: American Psychiatric Association; 1994.
20.
Benvenuti A, Rucci P, Ravani L, et al. : Psychotic features in borderline patients: is there a connection to mood dysregulation? Bipolar Disord 2005, 7:338–343.CrossRefPubMed
21.
•• Berenbaum H, Thompson RJ, Milanek ME, et al.: Psychological trauma and schizotypal personality disorder. J Abnorm Psychol 2008, 117:502–519. This study investigated the relationship between psychological trauma, PTSD, and schizotypal symptoms. PTSD criterion A was significantly associated with schizotypal symptoms. Furthermore, schizotypal symptoms were more strongly associated with childhood maltreatment among women than they were among men.
22.
Gracie A, Freeman D, Green S, et al.: The association between traumatic experience, paranoia and hallucinations: a test of the predictions of psychological models. Acta Psychiatr Scand 2007, 116:280–289.CrossRefPubMed
23.
Kilcommons AM, Morrison AP: Relationships between trauma and psychosis: an exploration of cognitive and dissociative factors. Acta Psychiatr Scand 2005, 112:351–359.CrossRefPubMed
24.
Dowson JH, Sussams P, Grounds AT, Taylor J: Associations of self-reported past “psychotic” phenomena with features of personality disorders. Compr Psychiatry 2000, 41:42–48.CrossRefPubMed
25.
Barnow S, Herpertz SC, Spitzer C, et al.: Temperament and character in patients with borderline personality disorder taking gender and comorbidity into account. Psychopathology 2007, 40:369–378.CrossRefPubMed
26.
Zanarini MC, Frankenburg FR, Yong L, et al.: Borderline psychopathology in the first-degree relatives of borderline and Axis II comparison probands. J Personal Disord 2004, 18:439–447.CrossRef
27.
Tyrer P: Primary article of discussion. Why borderline personality disorder is neither borderline nor a personality disorder. Personal Ment Health 2009, 3:86–95.
28.
Lake CR, Hurwitz N: Schizoaffective disorders are psychotic mood disorders; there are no schizoaffective disorders. Psychiatry Res 2006, 143:255–287.CrossRefPubMed
29.
Johnson DM, Shea MT, Yen S, et al.: Gender differences in borderline personality disorder: findings from the Collaborative Longitudinal Personality Disorders study. Compr Psychiatry 2003, 44:284–292.CrossRefPubMed
30.
Links PS, Heslegrave RJ, Mitton JE, et al.: Characteristics of borderline personality disorder: a Canadian study. Can J Psychiatry 1995, 33:336–354.
31.
Yen S, Shea MT, Pagano M, et al.: Axis I and Axis II disorders as predictors of prospective suicide attempts: findings from the Collaborative Longitudinal Personality Disorders study. J Abnorm Psychol 2003, 112:375–381. (Published erratum appears in J Abnorm Psychol 2004, 113:301.)
32.
• Smith MJ, Thirthalli J, Abdallah AB, et al.: Prevalence of psychotic symptoms in substance users: a comparison across substances. Compr Psychiatry 2009, 50:245–250. This is the first study examining the prevalence of psychotic symptoms in relation to specific substances and dependence severity. The authors demonstrated a high prevalence of psychotic symptoms in substance abusers and a positive relation between dependence severity and the experience of psychotic symptoms.
33.
Dowson JH, Sussams P, Grounds AT, Taylor J: Associations of self-reported past “psychotic” phenomena with features of personality disorders. Compr Psychiatry 2000, 41:42–48.CrossRefPubMed
34.
Miller FT, Abrams T, Dulit R, Fyer M: Psychotic symptoms in patients with borderline personality disorder and concurrent Axis I disorder. Hosp Community Psychiatry 1993, 44:59–61.PubMed
35.
Barnow S, Plock K, Spitzer C, et al.: Trauma, temperaments- und charaktermerkmale bei patienten mit borderline-persönlichkeitsstörung und komplexer posttraumatischer Belastungsstörung [in German]. Verhaltenstherapie 2005, 15:148–156.CrossRef
36.
van Winkel R, Stefanis NC, Myin-Germeys I: Psychosocial stress and psychosis. A review of the neurobiological mechanisms and the evidence for gene-stress interaction. Schizophr Bull 2008, 34:1095–1105.
37.
Shevlin M, Dorahy M, Adamson G: Childhood traumas and hallucinations: an analysis of the National Comorbidity Survey. J Psychiatr Res 2007, 41:222–228.CrossRefPubMed
38.
Spauwen J, Krabbendam L, Lieb R, et al.: Impact of psychological trauma on the development of psychotic symptoms: relationship with psychosis proneness. Br J Psychiatry 2006, 188:527–533.CrossRefPubMed
39.
Read J, Agar K, Argyle N, Aderhold V: Sexual and physical abuse during childhood and adulthood as predictors of hallucinations, delusions and thought disorder. Psychol Psychother 2003, 76:1–22.CrossRefPubMed
40.
Walter M, Bureau JF, Holmes BM, et al.: Cortisol response to interpersonal stress in young adults with borderline personality disorder: a pilot study. Eur Psychiatry 2008, 23:201–204.CrossRefPubMed
41.
Myin-Germeys I, van Os J: Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 2007, 27:409–424.CrossRefPubMed
42.
Collip D, Myin-Germeys I, Van Os J: Does the concept of “sensitization” provide a plausible mechanism for the putative link between the environment and schizophrenia? Schizophr Bull 2008, 34:220–225.CrossRefPubMed
43.
Paris J, Silk KR, Gunderson J, et al.: Formal rebuttal. The case for retaining borderline personality disorder as a psychiatric diagnosis. Personal Ment Health 2009, 3:96–100.
44.
Glaser JP, van Os J, Portegijs PJ, Myin-Germeys I: Childhood trauma and emotional reactivity to daily life stress in adult frequent attenders of general practitioners. J Psychosom Res 2006, 61:229–236.CrossRefPubMed
45.
White CN, Gunderson JG, Zanarini MC, Hudson JI: Family studies of borderline personality disorder: a review. Harv Rev Psychiatry 2003, 11:8–19.CrossRefPubMed
46.
• Distel MA, Trull TJ, Willemsen G, et al.: The five-factor model of personality and borderline personality disorder: a genetic analysis of comorbidity: Biol Psychiatry 2009, 66:1131–1138. Results of this study showed that genetic liability to BPD was accounted for by individual differences in neuroticism and other five-factor model personality traits. The authors discuss unique environmental influences that cause a specific pattern of personality traits to cross a threshold and develop into BPD.
47.
Li X, Sundquist J, Sundquist K: Age-specific familial risks of psychotic disorders and schizophrenia: a nation-wide epidemiological study from Sweden. Schizophr Res 2007, 97:43–50.CrossRefPubMed
48.
Zanarini MC, Barison LK, Frankenburg FR, et al.: Family history study of the familial coaggregation of borderline personality disorder with Axis I and nonborderline dramatic cluster Axis II disorders. J Pers Disord 2009, 23:357–369.CrossRefPubMed
49.
Stone MH, Kahn E, Flye B: Psychiatrically ill relatives of borderline patients: a family study. Psychiatr Q 1981, 53: 71–84.CrossRefPubMed
50.
Schulz PM, Soloff PH, Kelly T, et al.: A family history study of borderline subtypes. J Pers Disord 1989, 3:217–229.
51.
Honea R, Crow TJ, Passingham D, Mackay CE: Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005, 162:2233–2245.CrossRefPubMed
52.
Widiger TA: Personality disorders. In Advanced Personality, edn 1. Edited by Barone DF, Hersen M, Van Hasselt VB: New York: Plenum Press; 1998:335–352.
53.
Muntaner C, Garcia-Sevilla L, Fernandez A, Torrubia R: Personality dimension, schizotypal and borderline personality traits and psychosis proneness. Pers Individ Dif 1988, 9:257–268.CrossRef
54.
Krabbendam L, Janssen I, Bak M, et al.: Neuroticism and low self-esteem as risk factors for psychosis. Soc Psychiatry Psychiatr Epidemiol 2002, 37:1–6.CrossRefPubMed
55.
Wright IC, Rabe-Hesketh S, Woodruff PW, et al.: Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000, 157:16–25.PubMed
56.
•• Goldstein KE, Hazlett EA, New AS, et al.: Smaller superior temporal gyrus volume specificity in schizotypal personality disorder. Schizophr Res 2009, 112:14–23. The authors compare for the first time the brain structures of SPD and BPD patients. They found a reduced volume in the superior temporal cortex only in the SPD patients, whereas brain abnormalities in the amygdala and prefrontal regions were present in both disorders.
57.
Irle E, Lange C, Sachsse U: Reduced size and abnormal asymmetry of parietal cortex in women with borderline personality disorder. Biol Psychiatry 2005, 57:173–182.CrossRefPubMed
58.
Williams LM, Das P, Liddell BJ, et al.: Fronto-limbic and autonomic disjunctions to negative emotion distinguish schizophrenia subtypes. Psychiatry Res 2007, 155:29–44.CrossRefPubMed
59.
Kessler RM, Woodward ND, Riccardi P, et al.: Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol Psychiatry 2009, 65:1024–1031.CrossRefPubMed
60.
Grosjean B, Tsai GE: NMDA neurotransmission as a critical mediator of borderline personality disorder. J Psychiatry Neurosci 2007, 32:103–115.PubMed
61.
Lysaker PH, Wickett AM, Lancaster RS, Davis LW: Neurocognitive deficits and history of childhood abuse in schizophrenia spectrum disorders: associations with cluster B personality traits. Schizophr Res 2004, 68:87–94.CrossRefPubMed
62.
American Psychiatric Association Practice Guidelines: Practice guideline for the treatment of patients with borderline personality disorder. American Psychiatric Association. Am J Psychiatry 2001, 158(10 Suppl):1–52.
63.
Mosbacher A, Mosbacher J, Schmahl C, Malevani J: Behandlung der borderline-persönlichkeitsstörung mit atypischen antipsychotika [in German]. Nervenarzt 2007, 78:1003–1013.CrossRef
64.
Frankenburg FR, Zanarini MC: Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry 1993, 34:402–405.CrossRefPubMed
65.
Benedetti F, Sforzini L, Colombo C, et al.: Low dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998, 59:103–107.PubMed
66.
Stich K: Evaluation einer vorform der DBT-PTSD. Kognitive Traumatherapie mit Skills-Gruppe und Achtsamkeitstraining [master’s thesis]. 2009.
67.
Binks CA, Fenton M, McCarthy L, et al.: Pharmacological interventions for people with borderline personality disorder. Cochrane Database Syst Rev 2006, 1:CD005652/3.
68.
•• Bellino S, Paradiso E, Bogetto F: Efficacy and tolerability of pharmacotherapies for borderline personality disorder. CNS Drugs 2008, 22:671–692. This review reports on and discusses data from clinical trials, reviews, and meta-analyses concerning drug efficacy and tolerability in the treatment of BPD.
69.
Lis E, Greenfield B, Henry M, et al.: Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci 2007, 32:162–173.PubMed
70.
Zetzsche T, Frodl T, Preuss UW, et al.: Amygdala volume and depressive symptoms in patients with borderline personality disorder. Biol Psychiatry 2006, 60:302–310.CrossRefPubMed
71.
Reske M, Habel U, Kellermann T, et al.: Differential brain activation during facial emotion discrimination in first-episode schizophrenia. J Psychiatr Res 2009, 43:592–599.CrossRefPubMed
72.
Rametti G, Junque C, Vendrell P, et al.: Hippocampal underactivation in an fMRI study of word and face memory recognition in schizophrenia. Eur Arch Psychiatry Clin Neurosci 2009, 259:203–211.CrossRefPubMed
73.
Minzenberg MJ, Fana J, New AS, et al.: Fronto-limbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study. Psychiatry Res 2007, 155:231–243.CrossRefPubMed
74.
Gur RE, Turetsky BI, Cowell PE, et al.: Temporolimbic volume reductions in schizophrenia. Arch Gen Psychiatry 2000, 57:769–775.CrossRefPubMed
75.
New AS, Hazlett EA, Buchsbaum MS, et al.: Amygdala–prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology 2007, 32:1629–1640.CrossRefPubMed
76.
Fornito A, Yucel M, Dean B, et al.: Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology. Schizophr Bull 2009, 35:973–993.CrossRefPubMed
77.
Crespo-Facorro B, Kim J, Andreasen NC, et al.: Insular cortex abnormalities in schizophrenia: a structural magnetic resonance imaging study of first-episode patients. Schizophr Res 2000, 46:35–43. (Published erratum appears in Schizophr Res 2001, 51:183–184)
78.
Tebartz van Elst L, Hesslinger B, Thiel T, et al.: Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry 2003, 54:163–171.
79.
Gaser C, Nenadic I, Volz HP, et al.: Neuroanatomy of ‘hearing voices’: a frontotemporal brain structural abnormality associated with auditory hallucinations in schizophrenia. Cereb Cortex 2004, 14:91–96.CrossRefPubMed
80.
Schmahl CG, Vermetten E, Elzinga BM, Bremner JD: A positron emission tomography study of memories of childhood abuse in borderline personality disorder. Biol Psychiatry 2004, 55:759–765.CrossRefPubMed
81.
Schmahl CG, Bremner JD: Neuroimaging in borderline personality disorder. J Psychiatr Res 2006, 40:419–427.CrossRefPubMed
Metadaten
Titel
Borderline Personality Disorder and Psychosis: A Review
verfasst von
Sven Barnow
Elisabeth A. Arens
Simkje Sieswerda
Ramona Dinu-Biringer
Carsten Spitzer
Simone Lang
Publikationsdatum
01.06.2010
Verlag
Current Science Inc.
Erschienen in
Current Psychiatry Reports / Ausgabe 3/2010
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI
https://doi.org/10.1007/s11920-010-0107-9

Weitere Artikel der Ausgabe 3/2010

Current Psychiatry Reports 3/2010 Zur Ausgabe

ReviewPaper

Psychiatric Aspects of Chronic Fatigue Syndrome and Fibromyalgia

ReviewPaper

Anticoagulation and Psychotropic Medications

ReviewPaper

The Role of the Entorhinal Cortex in Paraphrenia

ReviewPaper

Excess Suicide Risk and Other External Causes of Death Among Women with Cosmetic Breast Implants: A Neglected Research Priority

ReviewPaper

Catatonia: Diagnosis, Classification, and Treatment

ReviewPaper

Psychiatric Aspects of Amyotrophic Lateral Sclerosis (ALS)

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise